NCT00219154View on ClinicalTrials.gov

A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazidebased Treatment Regimen With Optional Addition of Amlodipine

PHASE3CompletedINTERVENTIONAL
Enrollment

1,125

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

January 31, 2006

Study Completion Date

January 31, 2006

Conditions
Hypertension
Interventions
DRUG

aliskiren

Trial Locations (2)

Unknown

Investigative Centers

Novartis Pharmaceuticals, Basel

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00219154 - A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazidebased Treatment Regimen With Optional Addition of Amlodipine | Biotech Hunter | Biotech Hunter